iPSC EVs
iPSC Extracelluar Vesicles, EVs Purification Platform
Rapid Differentiation of Human iPSCs technologies and Large-Scale iPSC-EVs Production for Clinical Applications – Patent and Application.
We have developed an innovative method for rapidly guiding the differentiation of human induced pluripotent stem cells (iPSCs) and culture technologies, offering a promising approach for repairing or replacing damaged tissue in the future. In addition, we have established a large-scale iPSC-derived EVs production platform optimized for clinical applications. iPSC-EVs are enriched with regenerative factors, making them highly effective in promoting cell repair, modulating inflammation, and enhancing tissue regeneration. Our proprietary purification and lyophilization processes ensure high-purity, stable, and bioactive EV products suitable for various therapeutic applications.
Combined with our expertise in iPSC-EVs production, we are advancing next-generation regenerative medicine solutions for unmet clinical needs.
